What are Pervasive Developmental Disorders?
The
diagnostic category of pervasive developmental disorders (PDD) refers
to a group of disorders characterized by delays in the development of
socialization and communication skills. Parents may note symptoms as
early as infancy, although the typical age of onset is before 3 years
of age. Symptoms may include problems with using and understanding
language; difficulty relating to people, objects, and events; unusual
play with toys and other objects; difficulty with changes in routine or
familiar surroundings, and repetitive body movements or behavior
patterns. Autism (a developmental brain disorder characterized by
impaired social interaction and communication skills, and a limited
range of activities and interests) is the most characteristic and best
studied PDD. Other types of PDD include Asperger's Syndrome, Childhood
Disintegrative Disorder, and Rett's Syndrome. Children with PDD vary
widely in abilities, intelligence, and behaviors. Some children do not
speak at all, others speak in limited phrases or conversations, and
some have relatively normal language development. Repetitive play
skills and limited social skills are generally evident. Unusual
responses to sensory information, such as loud noises and lights, are
also common.
Is there any treatment?
What is the prognosis?
What research is being done?
Select this link to view a list of studies currently seeking patients.
National Dissemination Center for Children with Disabilities U.S. Dept. of Education, Office of Special Education Programs P.O. Box 1492 Washington, DC 20013-1492 [email protected] http://www.nichcy.org Tel: 800-695-0285 Fax: 202-884-8441 |
National Institute of Mental Health (NIMH) National Institutes of Health, DHHS 6001 Executive Blvd. Rm. 8184, MSC 9663 Bethesda, MD 20892-9663 [email protected] http://www.nimh.nih.gov Tel: 301-443-4513/866-615-NIMH (-6464) 301-443-8431 (TTY) Fax: 301-443-4279 |
National Institute on Deafness and Other
Communication Disorders Information Clearinghouse 1 Communication Avenue Bethesda, MD 20892-3456 [email protected] http://www.nidcd.nih.gov Tel: 800-241-1044 800-241-1055 (TTD/TTY) |
National Institute of Child Health and Human
Information Resource Center P.O. Box 3006 Rockville, MD 20847 [email protected] http://www.nichd.nih.gov Tel: 800-370-2943 888-320-6942 (TTY) Fax: 301-984-1473 |
MAAP Services for Autism, Asperger Syndrome, and PDD P.O. Box 524 Crown Point, IN 46308 [email protected] http://www.maapservices.org Tel: 219-662-1311 Fax: 219-662-0638 |
Autism Network International (ANI) P.O. Box 35448 Syracuse, NY 13235-5448 [email protected] http://ani.autistics.org |
Autism Research Institute (ARI) 4182 Adams Avenue San Diego, CA 92116 [email protected] http://www.autismresearchinstitute.com Tel: 619-281-7165 Fax: 619-563-6840 |
Autism National Committee (AUTCOM) P.O. Box 429 Forest Knolls, CA 94933 http://www.autcom.org |
National Organization for Rare Disorders (NORD) P.O. Box 1968 (55 Kenosia Avenue) Danbury, CT 06813-1968 [email protected] http://www.rarediseases.org Tel: 203-744-0100 Voice Mail 800-999-NORD (6673) Fax: 203-798-2291 |
American Speech-Language-Hearing Association
(ASHA) 10801 Rockville Pike Rockville, MD 20852-3279 [email protected] http://www.asha.org Tel: 800-638-8255 Fax: 301-571-0457 |
Source: National Institute of Neurological Disorders and Stroke
Dr. Jeffrey Speller
Dr. Tanya Korkosz
Psychopharmacology Associates of New England